- Moderna’s Shift to Cancer Company Lifts Stock Up 177% The New York Times —
- Skin cancer vaccine slashes risk of dying from the disease - giving hope to thousands Mirror —
- Moderna breakthrough: The options lottery tickets that paid out Seeking Alpha —
- Trump’s Moderna bet gets a double dose Seeking Alpha —
- Moderna nearly triples in record S&P 500 move, but analyst sees more volatility ahead Seeking Alpha —
- Moderna and Merck breakthrough could usher in wave of cancer vaccines TimesLIVE —
- Moderna’s experimental mRNA cancer treatment progresses, shares spike Global News —
- Breakthrough Personalized mRNA Vaccines Are Highly Effective Against Melanoma Skin Cancers Reason —
- Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rally MarketWatch —
- Personalized mRNA-based cancer vaccine shows promise 📹 ABC News — · 2min
- Vaccine breakthrough stops cancer returning in trial BBC News —
- Moderna’s and Merck’s personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring Fortune —
- Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma 📹 NBC News — · 2min
- Merck and Moderna say cancer vaccine shows signs of preventing recurrence of melanoma NBC News —
- Merck and Moderna say melanoma vaccine shows promise 📹 NBC News — · 24sec
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test CTV News —
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test Winnipeg Free Press —
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test The Independent —
- Moderna shares surge after it says its experimental mRNA cancer treatment passed a key test The Philadelphia Inquirer —
- Moderna, Merck say cancer vaccine trial marks ‘landmark moment’ UPI —
Moderna
American biotechnology company
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response. The company's name is derived from the terms "modified", "RNA", and "modern".
Also known as...
Moderna, Inc., Moderna Therapeutics, and Moderna Therapeutics, Inc.
Moderna-Merck cancer vaccine trial succeeds